Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Relay Therapeutics (RLAY)
NASDAQ:RLAY
Holding RLAY?
Track your performance easily
Relay Therapeutics (RLAY) Ownership Overview
3.00% Insiders
15.12% Mutual Funds
51.58% Other Institutional Investors
14.23% ETFs
16.06% Public Companies and
Individual Investors
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 80.94% of the company’s stock is owned by Institutional Investors, 3.00% is owned by Insiders, and 16.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 30, 2024 | Brian Adams Clo | xxxxxxxxxxxxx | $9890 |
| Oct 30, 2024 | xxxxxxxxxxxxx | $10284 | |
| Oct 30, 2024 | Donald A Bergstrom President, R&d | xxxxxxxxxxxxx | $16289 |
| Oct 30, 2024 | Peter Rahmer Chief Corporate Development Officer | xxxxxxxxxxxxx | $9823 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $304497 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $315444 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $701343 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1783976 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,711,059 | Institution | 8.19% | 69,994,956 | |
| 10,282,812 | Institution | 6.14% | 52,493,755 | |
| 5,262,013 | Institution | 3.14% | 26,862,576 | |
| 2,225,678 | Institution | 1.33% | 11,362,086 | |
| 2,128,033 | Insider | 1.27% | 10,863,608 | |
| 2,073,166 | Institution | 1.24% | 10,583,512 | |
| 1,613,462 | Institution | 0.96% | 8,236,724 | |
| 1,214,260 | Institution | 0.73% | 6,198,797 | |
| 1,160,117 | Institution | 0.69% | 5,922,397 | |
| 1,147,502 | Institution | 0.69% | 5,857,998 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,282,812 | Institution | 6.14% | 52,493,755 | |
| 2,073,166 | Institution | 1.24% | 10,583,512 | |
| 1,613,462 | Institution | 0.96% | 8,236,724 | |
| 1,214,260 | Institution | 0.73% | 6,198,797 | |
| 1,147,502 | Institution | 0.69% | 5,857,998 | |
| 1,025,770 | Institution | 0.61% | 5,236,556 | |
| 992,831 | Institution | 0.59% | 5,068,402 | |
| 781,324 | Institution | 0.47% | 3,988,659 | |
| 573,034 | Institution | 0.34% | 2,925,339 | |
| 568,998 | Institution | 0.34% | 2,904,735 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,889,947 | Institution | 2.92% | 34,620,825 | |
| 3,868,904 | Institution | 2.31% | 27,391,840 | |
| 2,130,528 | Institution | 1.27% | 15,084,138 | |
| 2,808,347 | Institution | 1.68% | 14,336,611 | |
| 1,894,249 | Institution | 1.13% | 13,411,283 | |
| 2,070,640 | Institution | 1.24% | 11,595,584 | |
| 951,971 | Institution | 0.57% | 4,859,812 | |
| 769,868 | Institution | 0.46% | 3,930,176 | |
| 608,533 | Institution | 0.36% | 3,407,785 | |
| 455,131 | Institution | 0.27% | 3,222,327 |
FAQ
Who Owns Relay Therapeutics (RLAY)?
According to the latest TipRanks data, approximately 51.58% of the company's stock is held by institutional investors, 3.00% is held by insiders, and 16.06% is held by retail investors.
What percentage of Relay Therapeutics (RLAY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.58% of Relay Therapeutics (RLAY) stock is held by institutional investors.
What percentage of Relay Therapeutics (RLAY) stock is held by retail investors?
According to the latest TipRanks data, approximately 16.06% of Relay Therapeutics (RLAY) stock is held by retail investors.
Who owns the most shares of Relay Therapeutics (RLAY)?
Vanguard owns the most shares of Relay Therapeutics (RLAY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.